For example, work by Trinder et al. [38] suggests that apoB is insufficient to explain Lp(a)-driven risk for CAD, and therefore it is unclear whether aggressive LDL-C and/or apoB lowering can fully offset risk from Lp(a). The gene discussed is APOB; the disease is coronary artery disorder.